AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

The positive trial results have not only demonstrated rosnilimab's potential in treating RA but have also validated AnaptysBio's scientific approach in targeting PD-1 co-inhibitory receptors on ...

AnaptysBio’s Phase IIb trial of its rheumatoid arthritis (RA) treatment, rosinilimab, has seen some patients achieve the ...

At Week 14, 69% (71% of b/tsDMARD-naïve and 66% of b/tsDMARD-experienced) or 220 of the 318 rosnilimab-treated patients across all doses achieved CDAI LDA and were eligible to remain on continued ...

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis.

ANSWER: Both RA and MCTD are rheumatologic diseases that affect many systems of the body. MCTD is often considered an overlap ...

Patients with late-onset rheumatoid arthritis experienced greater functional impairment over 5 years, compared against those with younger-onset disease.

Anesthesia does not cause dementia. However, some people do develop a complication called post-operative delirium.

My husband, who is 71, has been having some short-term memory problems over the past two years. We recently saw his primary doctor, who asked him some questions ...

Dear D.D.: Both RA and MCTD are rheumatologic diseases that affect many systems of the body. MCTD is often considered an overlap syndrome as it has features that resemble lupus, systemic sclerosis ...

The Trump administration’s efforts to curb research funding has put treatment for 9/11 first responders, studies of top causes of death in older women, and other life-saving programs on college ...